Literature DB >> 27196590

The gut-adherent microbiota of PSC-IBD is distinct to that of IBD.

Mohammed Nabil Quraishi1, Martin Sergeant2, Gemma Kay2, Tariq Iqbal3, Jacqueline Chan2, Chrystala Constantinidou2, Palak Trivedi1, James Ferguson1, David H Adams1, Mark Pallen2, Gideon M Hirschfield1.   

Abstract

Keywords:  GUT IMMUNOLOGY; INTESTINAL MICROBIOLOGY; PRIMARY SCLEROSING CHOLANGITIS

Mesh：

Year:  2016        PMID： 27196590     DOI： 10.1136/gutjnl-2016-311915

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  43 in total

Review 1.  The IBD and PSC Phenotypes of PSC-IBD.

Authors:  Amanda Ricciuto; Binita M Kamath; Anne M Griffiths
Journal:  Curr Gastroenterol Rep       Date:  2018-03-28

Review 2.  Genetics of primary sclerosing cholangitis and pathophysiological implications.

Authors:  Xiaojun Jiang; Tom H Karlsen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-15       Impact factor: 46.802

3.  Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function.

Authors:  Martin Kummen; Mette Vesterhus; Marius Trøseid; Bjørn Moum; Asbjørn Svardal; Kirsten Muri Boberg; Pål Aukrust; Tom Hemming Karlsen; Rolf Kristian Berge; Johannes Roksund Hov
Journal:  United European Gastroenterol J       Date:  2016-08-02       Impact factor: 4.623

4.  The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation.

Authors:  Elisabeth Schrumpf; Martin Kummen; Laura Valestrand; Thomas U Greiner; Kristian Holm; Velmurugesan Arulampalam; Henrik M Reims; John Baines; Fredrik Bäckhed; Tom H Karlsen; Richard S Blumberg; Johannes R Hov; Espen Melum
Journal:  J Hepatol       Date:  2016-10-05       Impact factor: 25.083

5.  Gut microbiome in liver pathophysiology and cholestatic liver disease.

Authors:  Shengmin Yan; Xiao-Ming Yin
Journal:  Liver Res       Date:  2021-08-08

Review 6.  Sex-related factors in autoimmune liver diseases.

Authors:  Dorothee Schwinge; Christoph Schramm
Journal:  Semin Immunopathol       Date:  2018-10-01       Impact factor: 9.623

7.  Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.

Authors:  James H Tabibian; Ahmad H Ali; Keith D Lindor
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-05

8.  The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease.

Authors:  J Torres; C Palmela; H Brito; X Bao; H Ruiqi; P Moura-Santos; J Pereira da Silva; A Oliveira; C Vieira; K Perez; S H Itzkowitz; J F Colombel; L Humbert; D Rainteau; M Cravo; C M Rodrigues; J Hu
Journal:  United European Gastroenterol J       Date:  2017-05-05       Impact factor: 4.623

9.  Short-chain fatty acid and fecal microbiota profiles are linked to fibrosis in primary biliary cholangitis.

Authors:  Craig Lammert; Andrea S Shin; Huiping Xu; Christopher Hemmerich; Thomas M O'Connell; Naga Chalasani
Journal:  FEMS Microbiol Lett       Date:  2021-04-22       Impact factor: 2.742

Review 10.  Gut microbiome, liver immunology, and liver diseases.

Authors:  Rui Wang; Ruqi Tang; Bo Li; Xiong Ma; Bernd Schnabl; Herbert Tilg
Journal:  Cell Mol Immunol       Date:  2020-12-14       Impact factor: 11.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.